Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 5 6 7 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Beiersdorf–S-Biomedic: skin microbiomics, 201807– collaboration 2018-07-18
DCPrime–Glycotope: cancer immunotherapy, 201807– license + collab agreement research new approaches to solid tumours 2018-07-18
S-Biomedic–Beiersdorf: investment, 201807 financing round Series A 1st closing totalling €2m incl lead investor Beiersdorf AG 2018-07-18
S-Biomedic–JnJ: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor JnJ Innovation JJDC 2018-07-18
S-Biomedic–SEVERAL: investment, 201807 financing round Series A 1st closing €2m led by Beiersdorf + incl investiere.ch + JnJ Innovation JJDC 2018-07-18
S-Biomedic–Verve Capital Partners: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor investiere.ch 2018-07-18
B Braun–CeGaT: personalised medicine, 201807 collab establishment of B Braun Precision Medicine Technology (Shanghai) Ltd 2018-07-17
CeGaT–B Braun: investment, 201807 existent 30% shareholding of B Braun in CeGaT 2018-07-17
Labfolder–NEC: information technology, 201807– collab €na combining Labfolder s/w with NEC hardware for scalable data storage solutions 2018-07-17
Polares Medical–Decheng Capital: investment, 201807 financing round totalling $25m incl lead investor Decheng Capital 2018-07-17
Polares Medical–Earlybird: investment, 201807 financing round totalling $25m incl co-investor Earlybird Venture Capital Berlin 2018-07-17
Polares Medical–Endeavour Vision: investment, 201807 financing round totalling $25m incl co-investor Endeavour Vision 2018-07-17
Polares Medical–IDO Investments: investment, 201807 financing round totalling $25m incl co-investor IDO Investments 2018-07-17
Polares Medical–SEVERAL: investment, 201807 financing round $25m led by Decheng Capital 2018-07-17
Polares Medical–Wellington Partners: investment, 201807 financing round totalling $25m incl co-investor Wellington Partners 2018-07-17
Roche–Shionogi: virostatic agent, 201807 license to baloxavir marboxil excl ww without JP + TW to Roche existent 2018-07-17
Holtzbrinck–Scott Partnership: public relations, 201807– supply service marcom for BioData 2018-07-16
Genmab–Immatics: cancer immunotherapy, 201807– researc collab + excl license to targets for biospecific I-O drugs $54m upfront + $550m milestones 2018-07-12
JPK Instruments–Bruker Corp: investment, 201807 acquisition €na of JPK by Bruker 2018-07-12
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
Forbion–SEVERAL: investment, 201807 first close €270m of Forbion IV fund 2018-07-11
BioNTech–Consilium: public relations, 201807 service existent international media relations + European IR by CSC 2018-07-10
BioNTech–Roivant: LNP technology, 201807– license excl to apply Genevant’s LNP delivery technology to 5 of BioNTech’s oncology programs 2018-07-10
BioNTech–Trophic Communications: public relations, 201807 service existent German media relations by Trophic 2018-07-10
BioNTech–Westwicke Partners: public relations, 201807 service existent US IR by Westwicke Partners 2018-07-10
Pionyr Immunotherapeutics–Minapharm: biopharma production, 201807– supply service cell line + process dev + prod of 2nd therap antibody by ProBioGen 2018-07-10
Roivant–BioNTech: mRNA therapeutics, 201807– collab strategic partnership to develop 5 products for rare disease with Genevant 2018-07-10
Boehringer–MabVax Therapeutics: antibody cancer drug, 201807 acquisition all rights to preclinical antibody program for solid tumours 2018-07-09
IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–Enpicom: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–EU (govt): grant, 201807– Eurostars grant €2m to develop clin validation for treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–OSE Immunotherapeutics: pharmacogenomics, 201807– collab project partner develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Ultimovacs: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Univ Hamburg: pharmacogenomics, 201807– collab partner Eurostars in project develop validation treatm response cancer vaccines 2018-07-05
Basilea–Coulter Partners: recruitment services, 201807 supply service placement of Gerrit Hauck as new CTO of Basilea Pharmaceutica Intl Ltd 2018-07-04
Lactotronic–Bruker Corp: investment, 201807 acquisition €na of Lactotronic BV by Bruker 2018-07-03
Novartis–France (govt): cell therapy contract manufacturing, 201807– supply production CAR-T cell therapies incl Kymriah by CellforCure 2018-07-01
NBE Therapeutics–Novo Group: investment, 201806 financing round Series B CHF20m extension by Novo Holdings bringing total Series B to CHF40m 2018-06-28
Bruker Corp–Cytosurge: cell analysis technology, 201806 collab product integration FluidFM techn on BioScope Resolve AMF for single cell analysis 2018-06-27
Nouscom–Minapharm: cell line, 201806– license to ProBioGen’s AGE1.CR duck cell line for production of viral vectored vaccines 2018-06-26
Exosome Diagnostics–Bio-Techne: investment, 201806– acquisition $250m cash + $325m milestones of Exosome Dx by Bio-Techne ANNOUNCED 2018-06-25
Exosome Diagnostics–Goodwin Procter: legal services, 201806 supply service legal counsel with regard to acquisition of Exosome Dx by Bio-Techne Corp 2018-06-25
Exosome Diagnostics–Moelis: financial services, 201806 supply service financial advisor with regard to acquisition of Exosome Dx by Bio-Techne Corp 2018-06-25
Univ Missouri–Bruker Corp: mass spectrometer, 201806 supply existent timsTOF Pro system at Univ of Missouri in Columbia MO 2018-06-25
Evonik–BRAIN: industrial biotechnology, 201806– collab with CyPlus to develop products for global mining industry 2018-06-20
iTeos Therapeutics–6 Dimensions Capital: investment, 201806 financing round Series B totalling €64m incl new + co-investor 6 Dimensions Capital 2018-06-20
iTeos Therapeutics–Belgium (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SFPI 2018-06-20
iTeos Therapeutics–Curative Ventures: investment, 201806 financing round Series B totalling €64m incl new + co-investor Curative Ventures 2018-06-20
iTeos Therapeutics–Fund+: investment, 201806 financing round Series B totalling €64m incl existing + co-investor Fund+ 2018-06-20
iTeos Therapeutics–HBM: investment, 201806 financing round Series B totalling €64m incl new + co-investor HBM Partners 2018-06-20
iTeos Therapeutics–MPM Capital: investment, 201806 financing round Series B totalling €64m incl new + lead investor MPM Capital 2018-06-20
iTeos Therapeutics–SEVERAL: investment, 201806 financing round Series B €64m led by MPM Capital 2018-06-20
iTeos Therapeutics–Univ Leuven: investment, 201806 financing round Series B totalling €64m incl existing + co-investor VIVES II 2018-06-20
iTeos Therapeutics–Wallonia (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SRIW 2018-06-20
TG Therapeutics–Novimmune: bispecific antibody, 201806– collab + excl license option ww for CD47/CD19 antibody NI-1701 (TG-1801) 2018-06-20
Foundation Medicine–Roche: investment, 201806–201807 acquisition all remaining shares for $2.4b in cash at $137/share 2018-06-19
UgiSense–SEVERAL: investment, 201806 second financing round 2018-06-19
Interactive Biosoftware–Sophia Genetics: investment, 201806 acquisition of IBS by Sophia Genetics 2018-06-16
Noxxon–SEVERAL: credit, 201806– convertible bond €380k from existing investors 2018-06-15
Sanofi–Evotec: investment, 201806–201807 acquisition integration of Sanofi’s infectious disease RnD in Lyon into Evotec 2018-06-15
Deinove–SEVERAL: investment, 201806 capital increase €8.5m with 3.148 new shares at €2.7/share 2018-06-14
Andrew Alliance–Omega Advisors: investment, 201806 financing round Series C totalling $14m incl Omega Funds 2018-06-12
Andrew Alliance–SEVERAL: investment, 201806 financing round Series C $14m incl Tecan + Waters + Inpeco + Rancilio Cube + Sam Eletr + Omega Funds 2018-06-12
Andrew Alliance–Tecan: investment, 201806 financing round Series C totalling $14m incl Tecan Group 2018-06-12
Andrew Alliance–Waters: investment, 201806 financing round Series C totalling $14m incl Waters Corp 2018-06-12
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
Univ Jena–ACD/Labs: cheminformatics, 201806 supply ACD/Spectrus Processor + ACD/NMR Workbook Suite + ACD/MS Workbook Suite 2018-06-12
Univ Jena–Bruker Corp: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Shimadzu: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Thermo Fisher: mass spectrometer, 201806 supply existent 2018-06-12
RSP Systems–SEVERAL: investment, 201806 financing round Series B first closing €6.5m incl family offices + private investors 2018-06-11
Roche–Microbiotica: microbiomics, 201806– collab multi-year up to $534m r+d + commerc of markers + targets + treatments for IBD w Genentech 2018-06-06
Roivant–Oxford BioMedica: Parkinson’s gene therapy, 201806– license ww excl to OXB-102 $30m upfront + $812.5m milestones to Axovant Sciences 2018-06-06
Gilead–Hookipa: therapeutic vaccine technology, 201806– collab + license $10m upfront r+d immunotherapies against HIV + HBV 2018-06-05
Secarna–MC Services: public relations, 201806 service existent by MC Services 2018-06-04
Sierra Sensors–Bruker Corp: investment, 201806 acquisition €na of Sierra Sensors GmbH by Bruker 2018-06-04
Univ Birmingham–Thermo Fisher: mass spectrometer, 201806 supply existent early customer Orbitrap ID-X Tribrid MS system at PCB 2018-06-04
Univ Greifswald–Bruker Corp: NMR spectrometer, 201806 supply installation of AVANCE IVDr at Greifswald Univ Hospital) 2018-06-01
Arix Bioscience–Evotec: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutchinson Cancer Center 2018-05-31
Arix Bioscience–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Evotec 2018-05-31
Evotec–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Arix Bioscience 2018-05-31
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
Univ Tübingen–ERS Genomics: CRISPR technology, 201804– license €na to NMI + NMI TT Pharmaservices to expand custom cell-based research services 2018-05-31
F-Star–Denali Therapeutics: investment, 201805 acquisition of F-Star Gamma Ltd via early exercise of option for asset-centric vehicle 2018-05-30
Five Prime–Roche: companion diagnostics, 201805– collab €na to develop IHC CDx assays for two cancer antibody candidates 2018-05-30
Ultra Scientific–Agilent: investment, 201805– acquisition of all business assets €na of Ultra Scientific by Agilent 2018-05-30
Aldeyra Therapeutics–Centogene: genomic services, 201805– collab identification of genetic markers for Sjögren-Larsson Syndrome using CentoMD 2018-05-29
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab expansion $6m to incl additional cell lines 2018-05-29
High-Tech Gründerfonds–Bayer: investment, 201805 Bayer invests in HTGF III 2018-05-29
High-Tech Gründerfonds–Boehringer: investment, 201805 BIVF invests in HTGF III 2018-05-29
High-Tech Gründerfonds–SEVERAL: investment, 201805 2nd closing of HTGF III €71.5m bringing total fund size to €316.5m 2018-05-29
Treeway–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-29
Lunaphore–Vitro (ES): in situ hybridisation, 201805– collab developm ISH protocols for RNA + DNA targets in tissue 2018-05-24
Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors 2018-05-24
Evotec–I’rom Group: iPSC technology, 201805– license non-excl for iPSCs produced with Sendai virus vector technology from ID Pharma 2018-05-23
Lava Therapeutics–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-23
Orphazyme–Centogene: biomarker discovery, 201805– collab service biomarkers for Gaucher disease clinical trial monitoring 2018-05-23
Samsung–Sphingotec: investment, 201805 acquisition of Nexus Dx Inc from Samsung via joint venture with CEO Nam Shin 2018-05-22
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab $65m upfront for cancer drugs 2018-05-21
Pierre Fabre–Roche: companion diagnostics, 201805– collab extension for developm of IHC CDx assay for ADC W0101 2018-05-18
next pagenext page 1 2 3 ... 5 6 7 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top